First in Human, Open Label, Dose Escalation Trial with Expansion Cohorts to Evaluate Safety of GEN1029 in Patents with Malignant Solid Tumors (GCT1029-01)
First in Human, Open Label, Dose Escalation Trial with Expansion Cohorts to Evaluate Safety of GEN1029 in Patents with Malignant Solid Tumors (GCT1029-01)
Trial Category:
Other Solid Tumor
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
